Dynamic changes in endothelial cell adhesion molecule nepmucin/CD300LG expression under physiological and...

Area of Science:

• Immunology
• Cell Biology
• Vascular Biology

Background:

• Vascular endothelial cells exhibit phenotypic plasticity in response to microenvironmental cues.
• Nepmucin (CD300LG) is a vascular endothelial adhesion molecule involved in lymphocyte interactions.

Purpose of the Study:

• To investigate the expression patterns of nepmucin/CD300LG in microvascular endothelial cells across various tissues.
• To determine the factors influencing nepmucin/CD300LG expression and its role in leukocyte trafficking.

Main Methods:

• Immunohistochemical analysis of nepmucin/CD300LG expression in diverse tissue microvasculature.
• Investigation of nepmucin/CD300LG regulation during acute inflammation (TNF-α) and in tumor microenvironments.
• Analysis of nepmucin/CD300LG expression in an animal model of chronic pancreatic islet inflammation (non-obese diabetes).

Main Results:

• Nepmucin/CD300LG exhibits constitutive, selective expression in most tissue microvessels but is downregulated in splenic red pulp, thymic medulla, and immunoprivileged sites.
• Expression decreases in lymph nodes during acute inflammation, partly mediated by TNF-α, and is downregulated in tumors.
• Nepmucin/CD300LG is induced in inflamed pancreatic islets, with infiltrating T cells expressing its ligand, suggesting a role in pathological T cell trafficking.

Conclusions:

• Nepmucin/CD300LG expression in microvascular endothelial cells is dynamically regulated by local tissue signals.
• Expression levels correlate with leukocyte infiltration, highlighting its role in immune cell trafficking in both physiological and pathological conditions.